Janux Therapeutics, Inc.
JANXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Janux Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 3,173 | $44.1K | SEC filing |
| FEDERATED HERMES, INC. | 2026-03-31 | 54,200 | $753K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 145 | $2.1K | SEC filing |
| KBC Group NV | 2026-03-31 | 1,387 | Not shown | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 741 | $10.3K | SEC filing |
| HRT FINANCIAL LP | 2026-03-31 | 366,699 | Not shown | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 604,000 | $8.4M | SEC filing |
| Connor, Clark & Lunn Investment Management Ltd. | 2026-03-31 | 119,376 | $1.66M | SEC filing |
| FOX RUN MANAGEMENT, L.L.C. | 2026-03-31 | 17,377 | $226K | SEC filing |
| Rangeley Capital, LLC | 2026-03-31 | 122,500 | $1.7M | SEC filing |
| Bayforest Capital Ltd | 2026-03-31 | 3 | $42 | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 36,620 | $509K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 55,988 | $778K | SEC filing |
| SIGNATUREFD, LLC | 2026-03-31 | 2,044 | $28.4K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 119,055 | $1.65M | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 58,800 | Not shown | SEC filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 2026-03-31 | 11,500 | $160K | SEC filing |
| CWM, LLC | 2026-03-31 | 554 | $7.7K | SEC filing |
| Bridgefront Capital, LLC | 2026-03-31 | 19,692 | $274K | SEC filing |
| Nuveen, LLC | 2026-03-31 | 97,120 | $1.35M | SEC filing |
- Each value is checked against Janux Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Janux Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Janux Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-10-18 · Lichter Jay: Larger than 84 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-10-18 · Lichter Jay: Larger than 83 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-09-12 · Lichter Jay: Larger than 82 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-09-12 · Lichter Jay: Larger than 81 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-06-03 · Avalon Ventures XI, L.P.: Larger than 85 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-06-03 · Reardon Tighe: Larger than 87 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-06-03 · Avalon Ventures XI, L.P.: Larger than 87 of the 88 other insider sales of Common Stock on file. SEC filing
- 2024-06-03 · Lichter Jay: Larger than 85 of the 88 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-02 | Doyle Janeen Noel · Chief Corp. & Bus. Dev. Ofcr | Common Stock | S — Open market or private sale | −4,059 | 14.03 | SEC filing |
| 2026-05-11 | Dobek Maria · Vice President, Accounting | Common Stock | S — Open market or private sale | −2,038 | 14.17 | SEC filing |
| 2026-01-02 | Meyer Andrew Hollman · Chief Business Officer | Common Stock | S — Open market or private sale | −1,879 | 13.73 | SEC filing |
| 2026-01-02 | Winter Charles M. · Chief Technical Officer | Common Stock | S — Open market or private sale | −2,401 | 13.73 | SEC filing |
| 2026-01-02 | DiRaimondo Thomas · Chief Scientific Officer | Common Stock | S — Open market or private sale | −2,505 | 13.73 | SEC filing |
| 2026-01-02 | McIver Zachariah · Chief Medical Officer | Common Stock | S — Open market or private sale | −2,714 | 13.73 | SEC filing |
| 2026-01-02 | Campbell David Alan · President and CEO | Common Stock | S — Open market or private sale | −8,072 | 13.73 | SEC filing |
| 2026-01-02 | Dobek Maria · Vice President, Accounting | Common Stock | S — Open market or private sale | −1,462 | 13.73 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Kung Winston · Director | Common Stock | A — Grant, award, or other acquisition | +5,500 | SEC filing |
| 2026-06-11 | Kung Winston · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +15,500 | SEC filing |
| 2026-06-11 | DOBMEIER ERIC · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +15,500 | SEC filing |
| 2026-06-11 | Simson Jake · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +15,500 | SEC filing |
| 2026-06-11 | Hernday Natasha · Director | Common Stock | A — Grant, award, or other acquisition | +5,500 | SEC filing |
| 2026-06-11 | Simson Jake · Director | Common Stock | A — Grant, award, or other acquisition | +5,500 | SEC filing |
| 2026-06-11 | Barrett Ronald W · Director | Common Stock | A — Grant, award, or other acquisition | +5,500 | SEC filing |
| 2026-06-11 | Barrett Ronald W · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +15,500 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-11-05 | Gujrathi Sheila · Director | Common Stock | J — Other acquisition or disposition | +4,611 | SEC filing |
| 2024-11-05 | CAPPS VICKIE L · Director | Common Stock | J — Other acquisition or disposition | +2,305 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.